Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Bezafibrate 400mg modified-release tablets |
| BNF code | 0212000D0AAABAB |
| Virtual Therapeutic Moiety | Bezafibrate |
| Date identifier became valid | 23 Sep 2020 |
| Previous product identifier | 319941006 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Bezafibrate |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 400.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Bezalip Mono 400mg modified-release tablets (Lexon (UK) Ltd) | |
| Bezalip Mono 400mg modified-release tablets (Necessity Supplies Ltd) | |
| Bezalip Mono 400mg modified-release tablets (Sigma Pharmaceuticals Plc) | |
| Bezalip Mono 400mg modified-release tablets (Teva UK Ltd) | |
| Lipozate 400mg modified-release tablets (Noumed Life Sciences Ltd) | |
| Virtual Medicinal Product Packs | |
| Bezafibrate 400mg modified-release tablets 28 tablet | |
| Bezafibrate 400mg modified-release tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.